Related Experiment Video
Updated: Nov 13, 2025

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
Published on: August 1, 2025
Cancer-associated fibroblasts: overview, progress, challenges, and directions
Qinrong Ping1,2, Ruping Yan3, Xin Cheng4
1Department of Urology, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, China.
Abstract:
Tumors are one of the main causes of death in humans. The development of safe and effective methods for early diagnosis and treatment of tumors is a difficult problem that needs to be solved urgently. It is well established that the occurrence of tumors involves complex biological mechanisms, and the tumor microenvironment (TME) plays an important role in regulating the biological behavior of tumors. Cancer-associated fibroblasts (CAFs) are a group of activated fibroblasts with significant heterogeneity and plasticity in the tumor microenvironment. They secrete a variety of active factors to regulate tumor occurrence, development, metastasis, and therapeutic resistance. Although most studies suggest that CAFs have significant tumor-promoting functions, some evidence indicates that they may have certain tumor-suppressive functions in the early stage of tumors. Current research on CAFs continues to face many challenges, and the heterogeneity of their origin, phenotype, and function is a major difficulty and hot spot. To provide new perspectives for the research on CAFs and tumor diagnosis and treatment, this review summarizes the definition, origin, biomarkers, generation mechanism, functions, heterogeneity, plasticity, subpopulations, pre-metastasis niches (PMN), immune microenvironment, and targeted therapy of CAFs, describes the research progress and challenges, and proposes possible future research directions based on existing reports.
Insights
Cancer-associated fibroblasts (CAFs) are key players in the tumor microenvironment, influencing tumor growth and treatment resistance. Understanding their complex roles and heterogeneity is crucial for developing new cancer therapies.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment Research
Background:
- Tumors are a leading cause of human mortality, necessitating advancements in early diagnosis and treatment.
- The tumor microenvironment (TME) significantly influences tumor progression, with cancer-associated fibroblasts (CAFs) playing a pivotal role.
- CAFs exhibit heterogeneity and plasticity, impacting tumor development, metastasis, and therapeutic resistance.
Purpose of the Study:
- To provide a comprehensive overview of cancer-associated fibroblasts (CAFs) within the tumor microenvironment.
- To explore the multifaceted roles, origins, biomarkers, and therapeutic implications of CAFs.
- To highlight current research challenges and propose future directions for CAF-targeted cancer therapies.
Main Methods:
- Literature review and synthesis of existing research on CAFs.
- Analysis of CAF heterogeneity, plasticity, and subpopulations.
- Examination of CAF interactions within the immune microenvironment and pre-metastasis niches (PMN).
Main Results:
- CAFs are heterogeneous cells with diverse origins, phenotypes, and functions.
- While often tumor-promoting, CAFs may exhibit tumor-suppressive roles in early cancer stages.
- CAF functions are critical in regulating tumor metastasis and resistance to therapies.
Conclusions:
- Addressing CAF heterogeneity is essential for understanding their complex roles in cancer.
- Targeting CAFs presents a promising avenue for novel cancer diagnostic and therapeutic strategies.
- Further research into CAF biology will advance personalized cancer treatment approaches.
Related Concept Videos
Introduction to Fibroblasts
The Tumor Microenvironment
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

